clinical trial · NCT07249788
Resmiterom Efficacy & Safety in Patients With MASH
Nabiqasim Industries (Pvt) Ltd·phase4·recruiting·n = 165
MASH - Metabolic Dysfunction-Associated SteatohepatitisResmetirom
brief summary
Phase 4 clinical trial study aims to further evaluate the safety and therapeutic efficacy of Resmetirom in Pakistani patients with fibroscan proven MASH.
started
Oct 17, 2025
primary completion
Oct 16, 2026
completion
Dec 31, 2026
last updated
Dec 3, 2025
official title
Clinical Evaluation of Safety and Efficacy of Resmiterom in Patients With MASH (Metabolic Dysfunction-Associated Steato-Hepatitis) A Prospective, Open-label, Interventional Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol